NeoLumina Bioscience In-Licenses Clinical-stage Psilocybin Product Candidate from Filament Health for Eating Disorders
PEX010 expands NeoLumina’s psychedelic product pipeline. Funding activity in process to advance clinical development. VANCOUVER, BRITISH COLUMBIA, CANADA, September 28, 2023 /EINPresswire.com/ -- NeoLumina Bioscience Inc. (“NeoLumina” or “the Company”) …